Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy recalls Heparin 20,000 U/Lidocaine 2% 10 mL/Sodium Bicarbonate 8.4% 10 mL/Sterile Water 5 mL, 27 mL Syringe, Anderson Compoundi…
- Recall date
- April 2, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1156-2019
- FDA classification
- Class II
- Brand / firm
- Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
- Sold / distributed
- Nationwide
Why it was recalled
Lack of sterility assurance.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Heparin 20,000 U/Lidocaine 2% 10 mL/Sodium Bicarbonate 8.4% 10 mL/Sterile Water 5 mL, 27 mL Syringe, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
Get recall alerts
Free email alert whenever Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy